Cancer and systemic inflammation: stage the tumour and stage the host
- PMID: 23921279
- PMCID: PMC3738113
- DOI: 10.1038/bjc.2013.418
Cancer and systemic inflammation: stage the tumour and stage the host
Comment on
-
Markers of systemic inflammation predict survival in patients with advanced renal cell cancer.Br J Cancer. 2013 Jul 9;109(1):147-53. doi: 10.1038/bjc.2013.300. Epub 2013 Jun 18. Br J Cancer. 2013. PMID: 23778526 Free PMC article. Clinical Trial.
References
-
- Guthrie GJ, Charles KA, Roxburgh CS, Horgan PG, McMillan DC, Clarke SJ. The systemic inflammation-based neutrophil-lymphocyte ratio: experience in patients with cancer. Crit Rev Oncol Hematol. 2013;S1040-8428 (13:00070–0007x. - PubMed
-
- McMillan DC. The systemic inflammation-based Glasgow Prognostic Score: a decade of experience in patients with cancer. Cancer Treat Rev. 2013;39:534–540. - PubMed
-
- Roxburgh CS, McMillan DC. Role of systemic inflammatory response in predicting survival in patients with primary operable cancer. Future Oncol. 2010;6:149–163. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
